These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21679017)

  • 21. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
    van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
    J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
    Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
    Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy.
    Marino K; Parlee A; Orlando R; Lerner L; Strymish J; Gupta K
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7273-5. PubMed ID: 26369958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis.
    Liss MA; Kim W; Moskowitz D; Szabo RJ
    J Urol; 2015 Aug; 194(2):397-402. PubMed ID: 25846415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ecology and fluoroquinolon resistance profiles in febrile urinary tract infections (FUTI) after prostate needle biopsy: A retrospective study in 466 biopsies].
    Duboureau H; Achkar K; Stephan R; Schmit JL; Saint F
    Prog Urol; 2017 May; 27(6):345-350. PubMed ID: 28478906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.
    Shakil J; Piracha N; Prasad N; Kopacz J; Tarasuk A; Farrell R; Urban C; Mariano N; Wang G; Segal-Maurer S
    Urology; 2014 Apr; 83(4):710-3. PubMed ID: 24680441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy.
    Suwantarat N; Dumford DM; Ponce-Terashima R; Kundrapu S; Zabarsky TF; Zhu H; Donskey CJ
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):973-6. PubMed ID: 23917913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.
    Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC
    J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature.
    Miura T; Tanaka K; Shigemura K; Nakano Y; Takenaka A; Fujisawa M
    Int J Urol; 2008 May; 15(5):457-9. PubMed ID: 18452466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences.
    Aparicio JR; Such J; Pascual S; Arroyo A; Plazas J; Girona E; Gutiérrez A; de Vera F; Palazón JM; Carnicer F; Pérez-Mateo M
    J Hepatol; 1999 Aug; 31(2):277-83. PubMed ID: 10453941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urosepsis and bacteraemia caused by antibiotic-resistant organisms after transrectal ultrasonography-guided prostate biopsy.
    Hadway P; Barrett LK; Waghorn DJ; Hasan K; Bdesha A; Haldar N; Kelleher J
    BJU Int; 2009 Dec; 104(11):1556-8. PubMed ID: 20053186
    [No Abstract]   [Full Text] [Related]  

  • 32. Febrile urinary tract infection after prostate biopsy and quinolone resistance.
    Choi JW; Kim TH; Chang IH; Kim KD; Moon YT; Myung SC; Kim JW; Kim MS; Kwon JK
    Korean J Urol; 2014 Oct; 55(10):660-4. PubMed ID: 25324949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases.
    Pinkhasov GI; Lin YK; Palmerola R; Smith P; Mahon F; Kaag MG; Dagen JE; Harpster LE; Reese CT; Raman JD
    BJU Int; 2012 Aug; 110(3):369-74. PubMed ID: 22313996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection after transrectal ultrasound-guided prostate biopsy.
    Lee SJ
    Korean J Urol; 2015 May; 56(5):346-50. PubMed ID: 25964834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection-related hospital admissions after transrectal biopsy of the prostate.
    Sanders A; Buchan N
    ANZ J Surg; 2013 Apr; 83(4):246-8. PubMed ID: 23346881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One preoperative dose randomized against 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy.
    Briffaux R; Coloby P; Bruyere F; Ouaki F; Pires C; Doré B; Irani J
    BJU Int; 2009 Apr; 103(8):1069-73; discussion 1073. PubMed ID: 19021604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy.
    Batura D; Rao GG; Nielsen PB
    BJU Int; 2010 Oct; 106(7):1017-20. PubMed ID: 20346055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: are we putting our patients at risk?
    Hori S; Sengupta A; Joannides A; Balogun-Ojuri B; Tilley R; McLoughlin J
    BJU Int; 2010 Nov; 106(9):1298-302; discussion 1302. PubMed ID: 20518764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epididymitis after transrectal ultrasound-guided needle biopsy of prostate gland.
    Donzella JG; Merrick GS; Lindert DJ; Andreini HJ; Curtis RL; Luna IH; Allen Z; Butler WM
    Urology; 2004 Feb; 63(2):306-8. PubMed ID: 14972477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.